Allero Therapeutics (Private limited company)

BE 0665.757.817 Active ●Onderstraat 7, 9000 Gand

Allero Therapeutics is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0665.757.817. It was founded on 04-11-2016. Its registered office is in Ghent. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € 68 509 and a loss of € 3 030. Addrly gives it a financial health grade of B, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for 3 of its last 4 financial years.

Information last updated on 10-10-2026.

Company information

Status
Active
Enterprise number
BE 0665.757.817
VAT registered
No
Founded
04-11-2016
Latest accounts
2025
Employees
-
Region
Flanders
Establishments
1
Filing record
On time 3 of 4 years
Peppol e-invoicing
Registered
Registered office
Onderstraat 7, 9000 Gand
Main activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE activities
21201 Fabrication de médicaments
21209 Fabrication d'autres produits pharmaceutiques
72101 Recherche-développement en biotechnologie

Key figures of Allero Therapeutics

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -3 030€ 123€ -11 756€ 254 322
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 68 509-4 %€ 71 5390 %€ 71 416-14 %€ 83 172
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 78 524-2 %€ 80 174-1 %€ 80 930-80 %€ 403 655
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -2 308-1 %€ -2 286+85 %€ -15 040€ 249 450
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
----

Financial estimate

Financial health grade B, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
1 mandate on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Ghent.

CompanyTown
Buckman Laboratories 9000 Gent
BELGICA 9000 Gent
RAINBOW ACTIVITIES 9000 Gent
RUYCKBORRE 9000 Gent
GHENT RECYCLING 9000 Gent
Terre N Mer 9000 Gent
B.O.N. ASSIST 9000 Gent
remedent 9000 Gent
Looking for more information about Allero Therapeutics?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is Allero Therapeutics still active? Yes. The Crossroads Bank for Enterprises lists Allero Therapeutics as active.

What is the VAT number of Allero Therapeutics? Allero Therapeutics is not registered for VAT. Its enterprise number is 0665.757.817.

When was Allero Therapeutics founded? Allero Therapeutics was founded on 04-11-2016.

What is the address of Allero Therapeutics? The current registered office of Allero Therapeutics is Onderstraat 7, 9000 Gand.

When did Allero Therapeutics last file annual accounts? The latest annual accounts of Allero Therapeutics were filed on 27-07-2026.

Does Allero Therapeutics file its annual accounts on time? Allero Therapeutics filed its annual accounts within the legal deadline for 3 of its last 4 financial years. Late: 2022.

Is Allero Therapeutics financially healthy? Addrly gives Allero Therapeutics a financial health grade of B, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is Allero Therapeutics profitable? The annual accounts of Allero Therapeutics for 2025 show a loss of € 3 030.

What is the equity of Allero Therapeutics? The equity of Allero Therapeutics was € 68 509 at the close of the 2025 financial year.

Who are the directors of Allero Therapeutics? The annual accounts of Allero Therapeutics record 1 mandate. The name, role and dates are visible with a free account.

Can Allero Therapeutics receive Peppol e-invoices? Yes. Allero Therapeutics is registered on the Peppol network and can receive structured electronic invoices.

What does Allero Therapeutics do? The main activity of Allero Therapeutics is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.

Sources

How Addrly builds and refreshes this data